| Vacaville Urgent Care | |
|
1001 Nut Tree Rd Ste 110 Vacaville CA 95687-4166 | |
| (707) 455-1343 | |
| (707) 455-7645 |
| Full Name | Vacaville Urgent Care |
|---|---|
| Speciality | Clinic/Center |
| Location | 1001 Nut Tree Rd, Vacaville, California |
| Authorized Official Name and Position | Gautam K Vadlamudi (PRESIDENT) |
| Authorized Official Contact | 7074551343 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Vacaville Urgent Care 1001 Nut Tree Rd Ste 110 Vacaville CA 95687-4166 Ph: (707) 455-1343 | Vacaville Urgent Care 1001 Nut Tree Rd Ste 110 Vacaville CA 95687-4166 Ph: (707) 455-1343 |
| NPI Number | 1831393255 |
|---|---|
| Provider Enumeration Date | 06/11/2007 |
| Last Update Date | 06/19/2014 |
| Medicare PECOS PAC ID | 4789741174 |
|---|---|
| Medicare Enrollment ID | O20090330000713 |
News Archive
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
In a Canadian first, Applied Brain Research Inc., and Ontario Centres of Excellence are pleased to announce that Intel's newest neuromorphic research chip, Loihi, will be demonstrated live at this year's Discovery conference.
Ipsen, an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.
Researchers at Cambridge University have identified five genetic clues for women who have a family history of breast cancer. The study brings up the number of common genetic variations linked to increased risk of breast cancer in women to 18. The study was published in Nature Genetics.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831393255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | A51500 (California) | Primary |
| Provider Name | Gautam K Vadlamudi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1184729212 PECOS PAC ID: 7517024904 Enrollment ID: I20090330000706 |
News Archive
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
In a Canadian first, Applied Brain Research Inc., and Ontario Centres of Excellence are pleased to announce that Intel's newest neuromorphic research chip, Loihi, will be demonstrated live at this year's Discovery conference.
Ipsen, an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.
Researchers at Cambridge University have identified five genetic clues for women who have a family history of breast cancer. The study brings up the number of common genetic variations linked to increased risk of breast cancer in women to 18. The study was published in Nature Genetics.
› Verified 9 days ago
News Archive
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
In a Canadian first, Applied Brain Research Inc., and Ontario Centres of Excellence are pleased to announce that Intel's newest neuromorphic research chip, Loihi, will be demonstrated live at this year's Discovery conference.
Ipsen, an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.
Researchers at Cambridge University have identified five genetic clues for women who have a family history of breast cancer. The study brings up the number of common genetic variations linked to increased risk of breast cancer in women to 18. The study was published in Nature Genetics.
› Verified 9 days ago
Community Medical Centers Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 Nut Tree Rd Ste 210, Vacaville, CA 95687 Phone: 707-359-1800 | |
Davita Renal Specialists Of California Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1360 Burton Dr, Suite 160, Vacaville, CA 95687 Phone: 707-446-4379 Fax: 707-446-4417 | |
Absolute Integrative Physical Medicine Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1490 Alamo Dr Ste B, Vacaville, CA 95687 Phone: 707-474-5688 Fax: 707-474-5658 | |
C & A Medical Group Corp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3000 Alamo Dr Ste 102, Vacaville, CA 95687 Phone: 707-567-3288 | |
Outpatient Wound Solutions, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 607 Elmira Rd, Suite 165, Vacaville, CA 95687 Phone: 707-999-0242 | |
Alpha Pregnancy Resource Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 138 S Orchard Ave, Vacaville, CA 95688 Phone: 707-449-8991 Fax: 707-469-6705 | |
Community Medical Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 Nut Tree Rd Ste 310, Vacaville, CA 95687 Phone: 707-359-1800 Fax: 707-359-1837 |